News

March 27, 2020March 27, 2020

Pulmonary Fibrosis Patient Spearheads Lung Transplant Foundation to Help Others

News

At 3 a.m. on July 6, 2003, Miami resident Jeffrey Goldstein got a call that would change his life. Doctors at the Duke University Lung Transplant Clinic had found ... Read more

March 27, 2020March 27, 2020

PHA Adds Four Newly Accredited Centers of Comprehensive Care to its Network

News, PH News

After demonstrating an ability to deliver top-shelf care to patients with pulmonary hypertension (PH), four sites have been added to the Pulmonary Hypertension Association’s (PHA) network of Centers of Comprehensive ... Read more

March 25, 2020March 25, 2020

Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19

News

Even with the coronavirus pandemic ravaging Europe and much of the world, patient advocate Lucia Monaco, PhD, of Italy remains confident that the Paris-based nonprofit she chairs will see ... Read more

March 25, 2020March 25, 2020

COVID-19 Patient with PH Treated with iNO Via Genosyl, VERO Biotech Announces

News, PH News

The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer ... Read more

March 23, 2020March 23, 2020

First-line Combo Therapy Best for Patients with CTD-PAH, Analysis Shows

News

People with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) — particularly those showing low or intermediate disease risk, typical PAH — benefit most from combination therapy with Letairis (ambrisentan) ... Read more

March 20, 2020March 20, 2020

Orenitram Tablets More Cost-effective Than Uptravi as PAH Treatment, Study Suggests

News, PAH News

Treatment with Orenitram (oral treprostinil) is associated with lower healthcare-related costs than treatment with Uptravi (selexipag) in people with pulmonary arterial hypertension (PAH), a new study suggests. The study, “Medication Adherence ... Read more

March 18, 2020March 19, 2020

Major Bleed Risk Higher With Warfarin Than Xarelto in CTEPH Patients, Study Finds

CTEPH News, News

Among people with chronic thromboembolic pulmonary hypertension (CTEPH), certain anticoagulants may reduce the risk of serious bleeding more than others, a new study shows. The study, “Real-life data of ... Read more

March 16, 2020March 16, 2020

Phase 2 Trial of Levosimendan in PH-HFpEF Patients Fully Enrolled

News

The Phase 2 HELP study testing levosimendan as a potential treatment for pulmonary hypertension (PH) has exceeded its target number and is fully enrolled, Tenax Therapeutics announced. The trial (NCT03541603), testing the potential ... Read more

March 13, 2020March 13, 2020

Bellerophon, FDA Agree on Design of Phase 3 INOPulse Clinical Trial

News, PH News

Bellerophon Therapeutics has reached an agreement with the U.S. Food and Drug Administration (FDA) setting the design of an upcoming, pivotal Phase 3 clinical trial testing INOpulse, an investigational ... Read more

March 11, 2020March 11, 2020

More PAH Cases in US Southwest than Registry Reports, Study Says

News, PAH News

The number of both new and existing cases of pulmonary arterial hypertension (PAH) in the southwestern U.S. population was found in a recent study to be higher than that ... Read more

Pin It on Pinterest